Skip to main content

Siemens Healthineers Stock Forecast, Price & News

-0.44 (-1.55 %)
(As of 05/12/2021 03:57 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume32,904 shs
Average Volume49,967 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SMMNY News and Ratings via Email

Sign-up to receive the latest news and ratings for Siemens Healthineers and its competitors with MarketBeat's FREE daily newsletter.

Siemens Healthineers logo

About Siemens Healthineers

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, diagnostic, and advanced therapies products and services to healthcare providers worldwide. The company operates through three segments; Imaging, Diagnostics, and Advanced Therapies. The Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. The Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics; and workflow solutions and informatics products. The Advanced Therapies segment offers integrated products, solutions, and services for therapy departments of healthcare providers; and robotic-assisted platform for endo-vascular coronary and peripheral vascular interventions. This segment's principal products include angiography systems and mobile C-arms. It also provides customer value chain services, including design, maintenance, operational management, training, and education services. In addition, the company offers equipment performance management, clinical education and e-learning, asset management, and managed departmental services, as well as digital health products and services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.


See More Headlines

Industry, Sector and Symbol

Industry Diagnostics & Research
Phone49 9131 84 0
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Next Earnings DateN/A
OptionableNot Optionable


Overall MarketRank

0.50 out of 5 stars

Medical Sector

1610th out of 2,042 stocks

Diagnostics & Research Industry

11th out of 15 stocks

Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Siemens Healthineers (OTCMKTS:SMMNY) Frequently Asked Questions

Is Siemens Healthineers a buy right now?

14 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Siemens Healthineers in the last year. There are currently 1 sell rating, 3 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Siemens Healthineers stock.
View analyst ratings for Siemens Healthineers
or view top-rated stocks.

What stocks does MarketBeat like better than Siemens Healthineers?

Wall Street analysts have given Siemens Healthineers a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Siemens Healthineers wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Siemens Healthineers?

Siemens Healthineers saw a increase in short interest in April. As of April 15th, there was short interest totaling 17,900 shares, an increase of 152.1% from the March 31st total of 7,100 shares. Based on an average daily volume of 90,100 shares, the days-to-cover ratio is currently 0.2 days.
View Siemens Healthineers' Short Interest

How has Siemens Healthineers' stock price been impacted by COVID-19 (Coronavirus)?

Siemens Healthineers' stock was trading at $19.98 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SMMNY shares have increased by 37.9% and is now trading at $27.55.
View which stocks have been most impacted by COVID-19

Who are Siemens Healthineers' key executives?

Siemens Healthineers' management team includes the following people:
  • Dr. Bernhard Montag, Pres, CEO & Chairman of Management Board (Age 52, Pay $2.81M)
  • Dr. Jochen Schmitz, CFO & Member of Management Board (Age 55, Pay $1.96M)
  • Dr. Christoph Zindel, Member of Management Board (Age 60, Pay $1.51M)
  • Ms. Darleen Caron, Chief HR Officer & Member of Management Board (Age 55)
  • Mr. Marc Koebernick, Head of Investor Relations
  • Mr. Michel Therin, Pres of Advanced Therapies (Age 60)
  • Martin Fischer, Head of Fin. Diagnostics
  • Christian Klaussner, Exec. VP of Fin.
  • Mr. Deepak S. Nath, Pres of Laboratory Diagnostics (Age 48)

Who are some of Siemens Healthineers' key competitors?

What is Siemens Healthineers' stock symbol?

Siemens Healthineers trades on the OTCMKTS under the ticker symbol "SMMNY."

How do I buy shares of Siemens Healthineers?

Shares of SMMNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Siemens Healthineers' stock price today?

One share of SMMNY stock can currently be purchased for approximately $27.55.

How many employees does Siemens Healthineers have?

Siemens Healthineers employs 54,500 workers across the globe.

What is Siemens Healthineers' official website?

The official website for Siemens Healthineers is

How can I contact Siemens Healthineers?

The company can be reached via phone at 49 9131 84 0.

This page was last updated on 5/13/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.